• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Proton therapy reduces the incidence of severe lymphopenia compared with photon

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Abravan, Azadeh
    Sitch, Peter
    van Herk, Marcel
    Gaito, Simona
    McPartlin, Andrew J
    Sashidaran, S.
    Smith, Ed
    Whitfield, Gillian
    Pan, Shermaine
    Affiliation
    The University of Manchester, Division of cancer sciences, MANCHESTER
    Issue Date
    2022
    
    Metadata
    Show full item record
    Abstract
    Purpose or Objective Radiotherapy-induced lymphopenia may be associated with adverse outcome and reduced survival in various cancer types. Due to unique dosimetric characteristics, proton therapy can reduce the volumes of healthy tissue irradiated, potentially sparing lymphocytes. We investigated the incidence of severe lymphopenia in patients treated with either photons or protons, whose radiation treatment site included head and neck (H&N) and central nervous system (CNS). Materials and Methods Data from 44 patients treated with proton therapy and 44 with photon therapy at a single institute for H&N (n=52) or CNS (n=36) were included. Base of skull treatment were included in the H&N category. All patients had lymphocyte counts at baseline (< 90 days prior to radiotherapy) and during radiotherapy. Severe lymphopenia grade 3 or higher was based on lymphocytes at nadir during RT < 0.5x109/L (CTCAE v5.0). If case of multiple clinical target volumes (CTVs), the largest CTV was used in the analysis. Vx was calculated from RT images and is a volume receiving x Gy or higher in the body normalized to body weight to account for patients’ size. For patients without weight data, it is imputed using a 3rd power fit of weight vs age from the available data. Multivariable logistic analysis was conducted to investigate the association between the incidence of severe lymphopenia and patients’ clinical, demographics, and dosimetric factors. To avoid multi-collinearity, dosimetric parameters were included in the multivariable regression one at a time together with other factors known to affect lymphocytes. Results Four (9%) and 17 (39%) of the patients developed grade 3 lymphopenia in the proton and photon treatment arm, respectively. There was a good match of baseline lymphocytes and CTV between proton and photon arms for each disease site (Table 1). However, lymphocyte counts during radiotherapy and the incidence of grade 2 and grade 3 lymphopenia was significantly lower in the proton arm. As seen in Table 2, in the univariable model, proton therapy was associated with the reduced risk of lymphopenia, however, it became insignificant when including dosimetric parameters in the multivariable model. Multivariable logistic regression adjusted for age, gender, treatment arm, and disease site suggested that lower baseline lymphocytes and larger volumes receiving 2‒30 Gy (V2, V5, V10, V20, V30) are associated with higher risk of developing grade 3 or higher lymphopenia during radiotherapy. Conclusion Our study suggests that in H&N and CNS treatment, protons reduce the risk of severe treatment-related lymphopenia. Proton therapy reduces the volume receiving low to intermediate doses (V2 -V30) and subsequently reduces grade 3 or higher lymphopenia.
    Citation
    Abravan A, Sitch P, van Herk M, Gaito S, McPartlin A, Sashidaran S, et al. Proton therapy reduces the incidence of severe lymphopenia compared with photon. Radiotherapy and Oncology. 2022 May;170:S140-S1. PubMed PMID: WOS:000806759200139.
    Journal
    Radiotherapy and Oncology
    URI
    http://hdl.handle.net/10541/625450
    Type
    Meetings and Proceedings
    Language
    en
    Collections
    All Christie Publications

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.